tiprankstipranks

Eric Fain Insider Profile

4 Followers
Eric Fain, Director at Orchestra BioMed Holdings, holds 99.63K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds 520.97K shares in Abbott Laboratories (Ticker: ABT), holds 80.15K shares in St Jude Medical (Ticker: STJ).
tipranks
Eric Fain

Eric Fain
Orchestra BioMed Holdings (OBIO)
Director

Ranked #12,157 out of 108,921 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+48.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$54M
98.94%
1.06%
A breakdown of Eric Fain's holdings

Insider Roles

Abbott Laboratories
(ABT)
Senior Vice President
Orchestra BioMed Holdings
(OBIO)
Director
Roles that Eric Fain holds in companies

Most Profitable Insider Trade

Stock:
Orchestra BioMed Holdings
(OBIO)
Rating:Informative Buy
Date:Aug 25, 2025 - Aug 25, 2026
Return:+106.10%
The most profitable trade made by Eric Fain

Eric Fain's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Orchestra BioMed Holdings
Aug 14, 2026
Director
Uninformative Sell
22.74K
$578.85K
STJ
St Jude Medical
Jan 06, 2017
Uninformative Sell
$6.48M
Abbott Laboratories
Jul 25, 2017
Senior Vice President
Uninformative Sell
1.42M
$53.85M
List of latest transactions for each holding click on a transaction to see Eric Fain's performance on stock

Eric Fain insider profile FAQ

What is the percentage of profitable transactions made by Eric Fain?
The percentage of profitable transactions made by Eric Fain is 100%.
    What is the average return per transaction made by Eric Fain?
    The average return per transaction made by Eric Fain is 48.30%.
      What stocks does Eric Fain hold?
      Eric Fain holds: OBIO, STJ, ABT stocks.
        What was Eric Fain’s latest transaction?
        Eric Fain latest transaction was an Uninformative Sell of $22.74K.
          What was Eric Fain's most profitable transaction?
          Eric Fain’s most profitable transaction was an Informative Buy of OBIO stock on August 25, 2025. The return on the trade was 106.10%.
            What is Eric Fain's role in Orchestra BioMed Holdings?
            Eric Fain's role in Orchestra BioMed Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.